These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31654891)

  • 41. Tiotropium may improve asthma symptoms and lung function in asthmatic patients with irreversible airway obstruction: the real-life data.
    Abadoglu O; Berk S
    Clin Respir J; 2016 Jul; 10(4):421-7. PubMed ID: 25335652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and Safety of Tiotropium in Children and Adolescents.
    Hamelmann E; Szefler SJ
    Drugs; 2018 Mar; 78(3):327-338. PubMed ID: 29368127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
    Halpin DM; Kaplan AG; Russell RK
    Respir Med; 2017 Jul; 128():28-41. PubMed ID: 28610667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of tiotropium administered by Respimat
    Sharma A; Kerstjens HA; Aalbers R; Moroni-Zentgraf P; Weber B; Dahl R
    Pulm Pharmacol Ther; 2017 Feb; 42():25-32. PubMed ID: 28039077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results.
    Bradley JM; Koker P; Deng Q; Moroni-Zentgraf P; Ratjen F; Geller DE; Elborn JS;
    PLoS One; 2014; 9(9):e106195. PubMed ID: 25188297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial.
    Vrijlandt EJLE; El Azzi G; Vandewalker M; Rupp N; Harper T; Graham L; Szefler SJ; Moroni-Zentgraf P; Sharma A; Vulcu SD; Sigmund R; Chawes B; Engel M; Bisgaard H
    Lancet Respir Med; 2018 Feb; 6(2):127-137. PubMed ID: 29361462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tiotropium Respimat Is Effective for the Treatment of Asthma at a Dose Lower Than That for Chronic Obstructive Pulmonary Disease.
    Chin SJ; Durmowicz AG; Chowdhury BA
    Ann Am Thorac Soc; 2016 Feb; 13(2):173-9. PubMed ID: 26650145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tiotropium in asthma poorly controlled with standard combination therapy.
    Kerstjens HA; Engel M; Dahl R; Paggiaro P; Beck E; Vandewalker M; Sigmund R; Seibold W; Moroni-Zentgraf P; Bateman ED
    N Engl J Med; 2012 Sep; 367(13):1198-207. PubMed ID: 22938706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease.
    Tang Y; Massey D; Zhong NS
    Chin Med J (Engl); 2013; 126(19):3603-7. PubMed ID: 24112149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis.
    Halpin DMG; Hamelmann EH; Frith PA; Moroni-Zentgraf PM; van Hecke B; Unseld A; Kerstjens HAM; Szefler SJ
    Pulm Ther; 2020 Jun; 6(1):131-140. PubMed ID: 32180164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of tiotropium on lung function in current smokers and never smokers with bronchial asthma.
    Yoshida M; Kaneko Y; Ishimatsu A; Komori M; Iwanaga T; Inoue H
    Pulm Pharmacol Ther; 2017 Feb; 42():7-12. PubMed ID: 27888045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bronchodilator Effect of Tiotropium via Respimat
    Ogasawara T; Sakata J; Aoshima Y; Tanaka K; Yano T; Kasamatsu N
    Intern Med; 2017 Sep; 56(18):2401-2406. PubMed ID: 28824055
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tiotropium Respimat in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials.
    Ratjen F; Koker P; Geller DE; Langellier-Cocteaux B; Le Maulf F; Kattenbeck S; Moroni-Zentgraf P; Elborn JS;
    J Cyst Fibros; 2015 Sep; 14(5):608-14. PubMed ID: 25819269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What is the role of tiotropium in asthma?: a systematic review with meta-analysis.
    Rodrigo GJ; Castro-Rodríguez JA
    Chest; 2015 Feb; 147(2):388-396. PubMed ID: 25322075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacodynamics and Pharmacokinetics Following Once-Daily and Twice-Daily Dosing of Tiotropium Respimat
    Beeh KM; Kirsten AM; Dusser D; Sharma A; Cornelissen P; Sigmund R; Moroni-Zentgraf P; Dahl R
    J Aerosol Med Pulm Drug Deliv; 2016 Oct; 29(5):406-415. PubMed ID: 26859538
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting β
    Hoshino M; Akitsu K; Ohtawa J
    J Asthma; 2019 Sep; 56(9):995-1003. PubMed ID: 30212239
    [No Abstract]   [Full Text] [Related]  

  • 59. Tiotropium for the treatment of adolescents with moderate to severe symptomatic asthma: a systematic review with meta-analysis.
    Rodrigo GJ; Castro-Rodríguez JA
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):211-6. PubMed ID: 26231467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy.
    Selya-Hammer C; Gonzalez-Rojas Guix N; Baldwin M; Ternouth A; Miravitlles M; Rutten-van Mölken M; Goosens LM; Buyukkaramikli N; Acciai V
    Ther Adv Respir Dis; 2016 Oct; 10(5):391-401. PubMed ID: 27405723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.